 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
10-19-2022
Insider Buy |
Venrock Healthcare Capital Partners II, L.P.
>10% Owner |
$10.68
CAGR »
|
$3,756,273.14
351,866 shares |
10-17-2022
Insider Buy |
Venrock Healthcare Capital Partners II, L.P.
>10% Owner |
$11.68
CAGR »
|
$2,043,302.16
174,966 shares |
10-11-2022
Insider Buy |
Venrock Healthcare Capital Partners II, L.P.
>10% Owner |
$11.91
CAGR »
|
$1,597,983.46
134,214 shares |
10-4-2022
Insider Buy |
Venrock Healthcare Capital Partners II, L.P.
>10% Owner |
$11.81
CAGR »
|
$2,634,811.00
223,100 shares |
10-3-2022
Insider Buy |
Venrock Healthcare Capital Partners II, L.P.
>10% Owner |
$10.75
CAGR »
|
$4,697,069.76
436,923 shares |
9-28-2022
Insider Buy |
Venrock Healthcare Capital Partners II, L.P.
>10% Owner |
$8.90
CAGR »
|
$5,225,027.84
587,214 shares |
9-7-2022
Insider Buy |
Venrock Healthcare Capital Partners II, L.P.
>10% Owner |
$11.53
CAGR »
|
$7,918,744.29
686,712 shares |
8-30-2022
Insider Buy |
Venrock Healthcare Capital Partners II, L.P.
>10% Owner |
$12.20
CAGR »
|
$610,000.00
50,000 shares |
7-29-2022
Insider Buy |
Venrock Healthcare Capital Partners II, L.P.
>10% Owner |
$9.21
CAGR »
|
$174,069.00
18,900 shares |
7-25-2022
Insider Buy |
Venrock Healthcare Capital Partners II, L.P.
>10% Owner |
$9.26
CAGR »
|
$687,181.05
74,199 shares |
7-20-2022
Insider Buy |
Venrock Healthcare Capital Partners II, L.P.
>10% Owner |
$9.18
CAGR »
|
$1,377,250.00
150,000 shares |
7-14-2022
Insider Buy |
Venrock Healthcare Capital Partners II, L.P.
>10% Owner |
$9.88
CAGR »
|
$934,815.33
94,573 shares |
7-5-2022
Insider Buy |
Venrock Healthcare Capital Partners II, L.P.
>10% Owner |
$9.61
CAGR »
|
$847,230.00
88,200 shares |
6-30-2022
Insider Buy |
Venrock Healthcare Capital Partners II, L.P.
>10% Owner |
$9.76
CAGR »
|
$613,509.92
62,870 shares |
6-16-2022
Insider Buy |
Venrock Healthcare Capital Partners II, L.P.
>10% Owner |
$9.69
CAGR »
|
$57,665.19
5,951 shares |
6-24-2022
Insider Buy |
Venrock Healthcare Capital Partners II, L.P.
>10% Owner |
$10.37
CAGR »
|
$5,101,091.60
492,020 shares |
6-14-2022
Insider Buy |
Venrock Healthcare Capital Partners II, L.P.
>10% Owner |
$8.57
CAGR »
|
$1,011,461.14
118,054 shares |
6-6-2022
Insider Buy |
Venrock Healthcare Capital Partners II, L.P.
>10% Owner |
$9.16
CAGR »
|
$1,748,709.45
190,871 shares |
6-9-2022
Insider Buy |
Venrock Healthcare Capital Partners II, L.P.
>10% Owner |
$9.65
CAGR »
|
$5,672,963.18
588,024 shares |
12-11-2020
Insider Buy |
Robert McKague
EVP, General Counsel |
$7.62
CAGR »
|
$76,200.00
10,000 shares |
12-10-2020
Insider Buy |
Geoffrey M. Parker
CFO and EVP |
$6.78
CAGR »
|
$101,700.00
15,000 shares |
5-12-2020
Insider Buy |
Geoffrey M. Parker
Chief Fin. Officer and EVP |
$30.09
CAGR »
|
$1,053,203.37
35,000 shares |
3-10-2020
Insider Buy |
Geoffrey M. Parker
Chief Fin. Officer and EVP |
$29.46
CAGR »
|
$147,300.00
5,000 shares |
11-19-2019
Insider Buy |
Geoffrey M. Parker
Chief Fin. Officer and Sr. VP |
$34.30
CAGR »
|
$686,015.80
20,000 shares |
8-13-2019
Insider Buy |
Geoffrey M. Parker
Chief Fin. Officer and Sr. VP |
$32.33
CAGR »
|
$969,869.92
30,000 shares |
4-3-2019
Insider Buy |
ORBIMED ADVISORS LLC
Director and >10% Owner |
$36.00
CAGR »
|
$8,100,000.00
225,000 shares |
4-3-2019
Insider Buy |
David P. Bonita
Director and >10% Owner |
$36.00
CAGR »
|
$8,100,000.00
225,000 shares |
11-13-2018
Insider Buy |
Geoffrey M. Parker
Chief Fin. Officer and Sr. VP |
$29.72
CAGR »
|
$148,600.00
5,000 shares |
7-2-2018
Insider Buy |
Brian M. Isern
>10% Owner |
$19.00
CAGR »
|
$8,800,002.00
463,158 shares |
7-2-2018
Insider Buy |
Longitude Capital Partners II, LLC
|
$19.00
CAGR »
|
$2,500,001.00
131,579 shares |
7-2-2018
Insider Buy |
Gerrit Klaerner
President and CEO |
$19.00
CAGR »
|
$300,010.00
15,790 shares |
7-2-2018
Insider Buy |
Geoffrey M. Parker
Chief Fin. Officer and Sr. VP |
$19.00
CAGR »
|
$1,140,000.00
60,000 shares |
7-2-2018
Insider Buy |
Edward J. Hejlek
SVP, General Counsel & Secy. |
$19.00
CAGR »
|
$250,002.00
13,158 shares |
7-2-2018
Insider Buy |
Jeroen B. Van Beek
Chief Comm Officer and Sr VP |
$19.00
CAGR »
|
$100,016.00
5,264 shares |
7-2-2018
Insider Buy |
Steffen Pietzke
VP Fin & Chief Acct Officer |
$19.00
CAGR »
|
$200,013.00
10,527 shares |
7-2-2018
Insider Buy |
Kathryn E. Falberg
|
$19.00
CAGR »
|
$600,001.00
31,579 shares |
7-2-2018
Insider Buy |
Sandra I. Coufal
|
$19.00
CAGR »
|
$8,800,002.00
463,158 shares |
7-2-2018
Insider Buy |
David P. Bonita
|
$19.00
CAGR »
|
$6,999,999.00
368,421 shares |
7-2-2018
Insider Buy |
ORBIMED ADVISORS LLC
|
$19.00
CAGR »
|
$6,999,999.00
368,421 shares |
7-2-2018
Insider Buy |
David Hirsch
|
$19.00
CAGR »
|
$2,500,001.00
131,579 shares |
Also See: Institutional Holders of TCDA
Also See: SEC filings
Below we present the annualized performance delivered by TCDA stock since 10-19-2022 (the date of the most recent
insider purchase). The performance of the investment from the time TCDA insider buying occurred is the ultimate
test of whether insiders were right about TCDA being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/20/2022 |
|
| End date: |
01/23/2023 |
|
| Start price/share: |
$11.41 |
|
| End price/share: |
$0.11 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.05% |
|
| Annualized Gain: |
-380.57% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$95.00 |
|
| Years: |
0.26 |
|
TCDA Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent TCDA insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding TCDA
|
|
Free TCDA Email Alerts:
